Back to Top Skip to main content Skip to sub-navigation

San Antonio volunteers sought for Warp Speed vaccine trials

Woman typing on laptop Marcy Edwards, a Military Health System beneficiary, signs up for Operation Warp Speed, Nov. 2, 2020. Operation Warp Speed is a national initiative to accelerate the development, production and distribution of COVID-19 vaccines, therapeutics and diagnostics. (Photo courtesy of Jason Edwards.)

Recommended Content:

COVID-19 Vaccine Efforts | Coronavirus | Vaccine Trials | COVID-19 Vaccine Toolkit

Two San Antonio area Military Health System facilities are seeking volunteers from among the military beneficiary population to participate in a COVID-19 vaccine trial.

The trial is part of Operation Warp Speed, a national initiative to accelerate the development, production and distribution of COVID-19 vaccines, therapeutics and diagnostics.

The Brooke Army Medical Center aboard Joint Base San Antonio-Fort Sam Houston, and the Wilford Hall Ambulatory Surgical Center at Joint Base San Antonio-Lackland are among the five Department of Defense locations taking part in the Phase III trial to evaluate the vaccine under development by AstraZeneca.

The other sites are Naval Medical Center San Diego in California, Walter Reed National Military Medical Center in Bethesda, Maryland, and Fort Belvoir Community Hospital in Virginia.

"The San Antonio Military Health System is proud to answer the call to help serve the needs of our nation in these unprecedented times," said Air Force Maj. Gen. John DeGoes, SAMHS market director and 59th Medical Wing commander. "We are proud to be selected as a partner in the effort to accelerate development of COVID-19 vaccines."

Army Brig. Gen. Shan Bagby, BAMC commanding general added, “We are honored to be among those sites selected in support of this whole-of government effort to ensure safe, effective medical products are provided at a critical time to the American people. SAMHS has the existing research infrastructure and experience to make a significant contribution to this important effort.”

The AstraZeneca vaccine trial is one of many national trials being conducted through Operation Warp Speed, and the first to encompass the DOD. With more than 80 sites nationwide, the trial has an overall target enrollment of 30,000 participants. Military sites are looking to draw 3,000 of those volunteers, according to a DOD release.

DOD sites are open on a voluntary basis to Military Health System beneficiaries – active duty, retirees and family members 18 years of age and older.

Beneficiaries can sign up for consideration by reaching out to either site:

Wilford Hall Ambulatory Surgical Center (Site Code: WHASC)
Recruitment Phone Number: 253-341-6170
Email: covidwhasc@genevausa.org 

Brooke Army Medical Center (Site Code: BAMC)
Recruitment Phone Number: 253-924-9458
Email: covidbamc@genevausa.org 

Alternatively, volunteers can also visit www.CoronavirusPreventionNetwork.org, click on “Volunteer Now” and complete the survey. When requested, volunteers should enter the appropriate site code, depending on their preference and geographic location.

Once the survey is completed, local study site coordinators will screen volunteers and contact those participants in their area who may be a good match for the study. Volunteers should consult with the study coordinator if they are scheduled to move, change their duty station or deploy within 12 months of beginning participation.

According to the DOD release, the study is looking for people who are at an increased risk of SARS-CoV-2 infection, which may include:

  • Working in an essential job, such as healthcare professions, emergency response personnel, grocery workers, meat-packing plants, restaurant staff, public transit, etc.
  • Living in densely populated residential environments
  • Living or working in congregated living facilities, such as nursing homes
  • A member of a community that has been hardest hit by this pandemic, such as older people, individuals with underlying health conditions, and racial/ethnic groups such as African Americans, Latino, and Native American populations.

Volunteers selected will be enrolled into the study. Once the local sites are active, participants will be called in to receive two doses of the vaccine or placebo about a month apart.

Along with scheduled visits, participants will be asked to come in if they have symptoms throughout the year to be tested for COVID-19. Study participants will be followed for two years to determine the vaccine’s efficacy, while being compensated for their participation.

You also may be interested in...

Get to Know the Vaccines

Publication
9/17/2021

A graphic showing the types of vaccines, how they work, and safety monitoring of the vaccines. Includes the MHS and TRICARE logos on the bottom right, and includes graphics of scientists, doctors, and patients.

Recommended Content:

COVID-19 Vaccine Toolkit | Get to Know the COVID-19 Vaccines

Get to know the COVID19 Vaccines

Publication
9/17/2021

Get to know the vaccines – they do not contain the live virus, they do not interact with our DNA, and have been tested rigorously.

Recommended Content:

COVID-19 Vaccine Toolkit | Get to Know the COVID-19 Vaccines

Line Leader Presentation (PDF)

Publication
8/4/2021

This document is identical to the PowerPoint presentation for line leader reference and use.

Recommended Content:

COVID-19 Vaccine Toolkit | COVID-19 Vaccine Toolkit | Coronavirus | COVID-19 Vaccine Efforts

Line Leader Presentation (Powerpoint)

Publication
8/4/2021

Leaders across the Department can leverage this briefing deck to discuss COVID-19 vaccines with their troops. Don't forget to reference speaker notes and to personalize the title slide!

Recommended Content:

COVID-19 Vaccine Toolkit | COVID-19 Vaccine Toolkit | Coronavirus | COVID-19 Vaccine Efforts

VAX Facts about Getting the COVID Vaccine at the Same Time as Others

Publication
6/9/2021

Printable PDF of VAX Fact Infographic

Recommended Content:

COVID-19 Vaccine Toolkit | COVID-19 Vax Facts

Get to Know the COVID-19 Vaccines (Combined)

Publication
6/9/2021

The Pfizer-BioNTech, Moderna, and Janssen (Johnson & Johnson) COVID-19 vaccines were developed to prevent infection from the virus that causes COVID-19. Learn about the vaccines, how they work and safety precautions.

Recommended Content:

COVID-19 Vaccine Toolkit | Get to Know the COVID-19 Vaccines | Getting the COVID-19 Vaccine | COVID-19 Vaccine Efforts

COVID-19 Vaccine Safety Monitoring

Publication
6/9/2021

The FDA and CDC continue to monitor the safety of COVID-19 vaccines. CDC has an independent group of experts that reviews all the safety data as it comes in and provides regular safety updates.

Recommended Content:

Get to Know the COVID-19 Vaccines | COVID-19 Vaccine Toolkit | COVID-19 Vaccine Efforts | Getting the COVID-19 Vaccine

Get to Know the COVID-19 Vaccines

Publication
6/9/2021

The Pfizer-BioNTech, Moderna, and Janssen (Johnson & Johnson) COVID-19 vaccines were developed to prevent infection from the virus that causes COVID-19.

Recommended Content:

COVID-19 Vaccine Toolkit | Get to Know the COVID-19 Vaccines | COVID-19 Vaccine Efforts | Getting the COVID-19 Vaccine

How COVID-19 Vaccines Work

Publication
6/9/2021

Learn how the different COVID-19 vaccines work.

Recommended Content:

COVID-19 Vaccine Toolkit | Get to Know the COVID-19 Vaccines | COVID-19 Vaccine Efforts | Getting the COVID-19 Vaccine

Airborne Hazards and Open Burn Pit Registry User Guide for Service Members

Publication
6/1/2021

The following guide is designed to help service members navigate the complete registry process. It describes the registry requirements; provides an in-depth, step-by-step guide for accessing, registering, and completing the Airborne Hazards and Open Burn Pit Registry questionnaire; and provides instructions for scheduling the optional, in-person medical exam.

Recommended Content:

Coronavirus | Airborne Hazards and Open Burn Pit Registry | Environmental Exposures

COVID-19 Vaccine Leader Card

Publication
5/27/2021

This printable card provides talking points when discussing the COVID-19 vaccine with servicemembers who are reluctant or indifferent to accepting the vaccine. The card lists common concerns and impressions, top 5 key messages, and supporting facts about the vaccine.

Recommended Content:

COVID-19 Vaccine Toolkit | Get to Know the COVID-19 Vaccines | COVID-19 Vax Facts

Unit Leader Vaccine Conversation Guide

Publication
5/24/2021

This guide offers approaches and illustrative examples for preparation, delivery, and navigation of small group discussions (recommended 1-5 people to facilitate greatest engagement) with servicemembers reluctant or indifferent to accepting the vaccine. The guide promotes an open dialogue regarding vaccine hesitancy and complacency by addressing concerns, building trust, and boosting vaccine confidence.

Recommended Content:

COVID-19 Vaccine Toolkit | Get to Know the COVID-19 Vaccines | COVID-19 Vax Facts

Provider Vaccine Conversation Guide

Publication
5/24/2021

This guide offers approaches and illustrative examples for Military Health System (MHS) providers to discuss the COVID-19 vaccine with servicemembers during routine visits. Initiating a COVID-19 vaccine conversation during servicemember visits will allow you to effectively address concerns, build trust, and boost vaccine confidence.

Recommended Content:

COVID-19 Vaccine Toolkit | Get to Know the COVID-19 Vaccines | COVID-19 Vax Facts

COVID-19 Vaccine Approved for Adolescents Ages 12 and Over

Publication
5/13/2021

The Pfizer-BioNTech vaccine is approved for those ages 12 and over. Includes a photo of adolescents at the top of the page, has the TRICARE logo at the bottom right. Links in the content include www.TRICARE.mil/VaccineAppointments and www.Vaccines.gov.

Recommended Content:

COVID-19 Vaccine Toolkit | Vaccine Eligibility

VAX Facts How Long does Protection Last?

Publication
4/21/2021

Printable PDF of VAX Fact Infographic

Recommended Content:

COVID-19 Vaccine Toolkit | COVID-19 Vax Facts
<< < 1 2 3 4 5 > >> 
Showing results 1 - 15 Page 1 of 5

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.